{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:17:08Z","timestamp":1778566628492,"version":"3.51.4"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>\n                    Coccidioidomycosis is a significant fungal disease primarily endemic to the southern United States, northern Mexico, and South America. Coccidioidomycosis is non-endemic in China, with only approximately 47 cases reported over the past 63 years. Recognizing that increased global travel is altering regional disease epidemiology, the Chinese Health Commission has classified\n                    <jats:italic>Coccidioides<\/jats:italic>\n                    species as highly pathogenic pathogens. The diagnosis of coccidioidomycosis poses a major challenge in China for medical institutions without biosafety level 3 (BSL-3) laboratories. In November 2021, we diagnosed a case of imported cutaneous coccidioidomycosis caused by\n                    <jats:italic>C. posadasii<\/jats:italic>\n                    from the United States. Shortly after returning from Arizona, USA, the patient presented with pneumonia-like symptoms accompanied by erythematous skin rash. The diagnosis was confirmed by next-generation sequencing (NGS), direct microscopy, histopathological examination and fungal culture. The patient had fatty liver disease with elevated liver enzymes. During treatment with oral fluconazole (400 mg daily), liver enzyme levels fluctuated persistently, and the patient exhibited intolerance to liposomal amphotericin B. Following proactive weight reduction and lipid-lowering therapy, along with intermittent administration of fluconazole, the patient's liver enzymes normalized. In October 2025, a 2-week course of liposomal amphotericin B led to clinical improvement, although direct microscopy remained positive. The patient is currently continuing fluconazole treatment. This case suggests that infections caused by highly pathogenic fungi in non-endemic regions may represent a major public health challenge globally, encompassing limitations in diagnostic tools, lack of treatment experience, and biosafety concerns.\n                  <\/jats:p>","DOI":"10.3389\/fpubh.2026.1833316","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:45:09Z","timestamp":1778564709000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis, treatment, and biosafety protection of imported highly pathogenic cutaneous fungal infection: a case-based study of cutaneous coccidioidomycosis"],"prefix":"10.3389","volume":"14","author":[{"given":"Yuhua","family":"Weng","sequence":"first","affiliation":[{"name":"Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujiao","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hangzhou Third People's Hospital, Hangzhou Third Hospital Affiliated to Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"B1","unstructured":"Notice of the National Health Commission on Issuing the Catalog of Pathogenic Microorganisms Transmitted Among Humans (No. Guo Wei Ke Jiao Fa [2023] 24)\n          \n          2023"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1056\/NEJMra2306821","article-title":"Coccidioidomycosis and histoplasmosis in immunocompetent persons","volume":"390","author":"Galgiani","year":"2024","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/head.12246","article-title":"CARE Group. The CARE guidelines: consensus-based clinical case reporting guideline development","volume":"53","author":"Gagnier","year":"2013","journal-title":"Headache"},{"key":"B5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s12879-016-1902-7","article-title":"The habitat of Coccidioides spp. and the role of animals as reservoirs and disseminators in nature","volume":"16","author":"Del Roc\u00edo Reyes-Montes","year":"2016","journal-title":"BMC Infect Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/myc.12750","article-title":"Coccidioidomycosis: imported and possible domestic cases in China: a case report and review, 1958-2017","volume":"61","author":"Liang","year":"2018","journal-title":"Mycoses."},{"key":"B7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/22221751.2021.1889931","article-title":"Application of laser capture microdissection and PCR sequencing in the diagnosis of Coccidioides spp. infection: a case report and literature review in China","volume":"10","author":"Yang","year":"2021","journal-title":"Emerg Microbes Infect."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1101\/gr.087551.108","article-title":"Comparative genomic analyses of the human fungal pathogens Coccidioides and their relatives","volume":"19","author":"Sharpton","year":"2009","journal-title":"Genome Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1534\/g3.115.022806","article-title":"Comparative phylogenomics of pathogenic and nonpathogenic species","volume":"6","author":"Whiston","year":"2016","journal-title":"G3."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1080\/21505594.2018.1509667","article-title":"Coccidioides immitis and posadasii; A review of their biology, genomics, pathogenesis, and host immunity","volume":"9","author":"Kirkland","year":"2018","journal-title":"Virulence."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1093\/oxfordjournals.molbev.a026399","article-title":"A test for concordance between the multilocus genealogies of genes and microsatellites in the pathogenic fungus Coccidioides immitis","volume":"17","author":"Fisher","year":"2000","journal-title":"Mol Biol Evol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"9067","DOI":"10.1073\/pnas.132178099","article-title":"Disease surveillance in recombining pathogens: multilocus genotypes identify sources of human Coccidioides infections","volume":"99","author":"Fisher","year":"2002","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.3201\/eid2206.151565","article-title":"Use of population genetics to assess the ecology, evolution, and population structure of Coccidioides","volume":"22","author":"Teixeria","year":"2016","journal-title":"Emerg Inf Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1004762","DOI":"10.1371\/journal.ppat.1004762","article-title":"Dust devil: the life and times of the fungus that causes valley Fever","volume":"11","author":"Lewis","year":"2015","journal-title":"PLoS Pathog."},{"key":"B15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/BF00442634","article-title":"Morphogenesis throughout saprobic and parasitic cycles of Coccidioides immitis","volume":"78","author":"Huppert","year":"1982","journal-title":"Mycopathologia."},{"key":"B16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1128\/CMR.00005-13","article-title":"Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis","volume":"26","author":"Nguyen","year":"2013","journal-title":"Clin Microbiol Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0129522","DOI":"10.1371\/journal.pone.0129522","article-title":"3rd, Hastey CJ, Hodge GC, Lunetta JM, Pappagianis D, et al. Coccidioides endospores and spherules draw strong chemotactic, adhesive, and phagocytic responses by individual human neutrophils","volume":"10","author":"Lee","year":"2015","journal-title":"PLoS ONE"},{"key":"B18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/13693780600928503","article-title":"The weapon potential of human pathogenic fungi","volume":"44","author":"Casadevall","year":"2006","journal-title":"Med Mycol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.1093\/cid\/ciw360","article-title":"Infectious diseases society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis","volume":"63","author":"Galgiani","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.pjnns.2016.12.004","article-title":"An unusual presentation of Listeria monocytogenes rhombencephalitis","volume":"51","author":"Acewicz","year":"2017","journal-title":"Neurol Neurochir Pol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/cid\/cix881","article-title":"Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases","volume":"66","author":"Simner","year":"2018","journal-title":"Clin Infect Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.arcmed.2016.08.004","article-title":"Diagnosis of sepsis with cell-free DNA by next-generation sequencing technology in ICU patients","volume":"47","author":"Long","year":"2016","journal-title":"Arch Med Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"S231","DOI":"10.1093\/cid\/ciy693","article-title":"Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice","volume":"67","author":"Miao","year":"2018","journal-title":"Clin Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1186\/s12879-021-06661-z","article-title":"Detection of Coccidioides posadasii in a patient with meningitis using metagenomic next-generation sequencing: a case report","volume":"21","author":"Mao","year":"2021","journal-title":"BMC Infect Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/dc.21613","article-title":"An atypical morphologic presentation of Coccidioides spp. in fine-needle aspiration of lung","volume":"40","author":"Schuetz","year":"2012","journal-title":"Diagn Cytopathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1128\/JCM.36.12.3721-3723.1998","article-title":"Misleading manifestations of Coccidioides immitis in vivo","volume":"36","author":"Kaufman","year":"1998","journal-title":"J Clin Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.5858\/2006-130-97-UFOISC","article-title":"Unusual forms of immature sporulating Coccidioides immitis diagnosed by fine-needle aspiration biopsy","volume":"130","author":"Ke","year":"2006","journal-title":"Arch Pathol Lab Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/ajcp\/99.5.582","article-title":"Fine-needle aspiration biopsy of pulmonary coccidiodomycosis. Spectrum of cytologic findings in 73 patients","volume":"99","author":"Raab","year":"1993","journal-title":"Am J Clin Pathol."},{"key":"B29","first-page":"105","article-title":"Increase in coccidioidomycosis - California, 2000\u20132007","volume":"58","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.rmed.2012.02.004","article-title":"Endemic mycoses: overlooked causes of community acquired pneumonia","volume":"106","author":"Hage","year":"2012","journal-title":"Resp Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/CLEP.S34434","article-title":"3rd. Coccidioidomycosis: epidemiology","volume":"5","author":"Brown","year":"2013","journal-title":"Clin Epidemiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.idc.2021.03.010","article-title":"3rd","volume":"35","author":"Bays","year":"2021","journal-title":"Coccidioidomycosis. Infect Dis Clin North Am."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e02293","DOI":"10.1128\/AAC.02293-17","article-title":"Evaluation of Amphotericin B lipid formulations for treatment of severe coccidioidomycosis","volume":"62","author":"Sidhu","year":"2018","journal-title":"Antimicrob Agents Chemother."},{"key":"B34","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s11046-017-0240-7","article-title":"3rd. Liposomal amphotericin B as monotherapy in relapsed coccidioidal meningitis","volume":"183","author":"Stewart","year":"2018","journal-title":"Mycopathologia"},{"key":"B35","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1080\/14787210.2016.1199272","article-title":"Antifungal agents and liver toxicity: a complex interaction","volume":"14","author":"Tverdek","year":"2016","journal-title":"Expert Rev Anti Infect Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1128\/AAC.01657-09","article-title":"Systematic review and meta-analysis of the tolerability and hepatotoxicity of antifungals in empirical and definitive therapy for invasive fungal infection","volume":"54","author":"Wang","year":"2010","journal-title":"Antimicrob Agents Chemother."},{"key":"B37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/jof4040133","article-title":"Pre-existing liver disease and toxicity of antifungals","volume":"4","author":"Spernovasilis","year":"2018","journal-title":"J Fungi (Basel)."},{"key":"B38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism."},{"key":"B39","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/infdis\/153.5.933","article-title":"Influence of fungal surface components on the interaction of Coccidioides immitis with polymorphonuclear neutrophils","volume":"153","author":"Frey","year":"1986","journal-title":"J Infect Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3390\/jof12030181","article-title":"drug interactions for inhibition or killing of coccidioides species","volume":"12","author":"Stevens","year":"2026","journal-title":"J Fungi."},{"key":"B41","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11046-015-9935-9","article-title":"Mini-review of published reports on coccidioidomycosis in China","volume":"180","author":"Wang","year":"2015","journal-title":"Mycopathologia."},{"key":"B42","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/cid\/cis1028","article-title":"Coccidioidomycosis acquired in Washington State","volume":"56","author":"Marsden-Haug","year":"2013","journal-title":"Clin Infect Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3201\/eid2508.190023","article-title":"Delays in Coccidioidomycosis diagnosis and associated healthcare utilization, Tucson, Arizona, USA","volume":"25","author":"Donovan","year":"2019","journal-title":"Emerg Infect Dis."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1833316\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T05:45:12Z","timestamp":1778564712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1833316\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":43,"alternative-id":["10.3389\/fpubh.2026.1833316"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1833316","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"article-number":"1833316"}}